AntineoplasticsLiver dysfunction: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1409卷 / 1期

关键词：

Lymphoma; Liver Dysfunction; Marginal Zone Lymphoma; Therapy Reduction; Lymphoma Subtype;

D O I：

10.2165/00128415-201214090-00031

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[1] AntineoplasticsLiver dysfunction: 15 case reports
Reactions Weekly, 2017, 1633 (1) : 60 - 60
[2] AntineoplasticsLiver dysfunction: case report
Reactions Weekly, 2017, 1667 (1) : 31 - 31
[3] AntineoplasticsLiver disorders: 2 case reports
Reactions Weekly, 2007, 1138 (1) : 8 - 8
[4] AntineoplasticsLiver toxicities: 6 case reports
Reactions Weekly, 2019, 1761 (1) : 53 - 53
[5] AntineoplasticsLiver injury: 7 case reports
Reactions Weekly, 2019, 1747 (1) : 33 - 33
[6] AntineoplasticsLiver transplant rejection: 3 case reports
Reactions Weekly, 2009, 1274 (1) : 8 - 9
[7] AntineoplasticsLiver, skin and gastrointestinal toxicity: 2 case reports
Reactions Weekly, 2017, 1675 (1) : 39 - 39
[8] RisperidoneHyperprolactinaemia and sexual dysfunction: 9 case reports
Reactions Weekly, 2011, 1340 (1) : 35 - 35
[9] AntineoplasticsLiver function damage and hand-foot syndrome: 2 case reports
Reactions Weekly, 2022, 1927 (1) : 69 - 69
[10] AntineoplasticsLiver failure, myelodysplastic syndrome and acute lymphocytic leukaemia: 3 case reports
Reactions Weekly, 2019, 1740 (1) : 35 - 35

← 1 2 3 4 5 →